C
Cannara Biotech Inc
XTSX:LOVE
Cannara Biotech Inc
XTSX:LOVE
Price:
1.83
CAD
-2.14%
Market Closed
Market Cap:
CA$175.3m
Cash Flow Statement
Cash Flow Statement
Cannara Biotech Inc
Cannara Biotech Inc
Currency: CAD
| Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(13)
|
(14)
|
(11)
|
(7)
|
(2)
|
1
|
1
|
1
|
2
|
3
|
3
|
5
|
7
|
9
|
6
|
5
|
6
|
7
|
13
|
16
|
13
|
12
|
|
| Depreciation & Amortization |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
6
|
7
|
7
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
3
|
|
| Other Non-Cash Items |
1
|
2
|
2
|
1
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
4
|
3
|
0
|
1
|
(3)
|
1
|
7
|
10
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
5
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Change in Working Capital |
(0)
|
(1)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(6)
|
(11)
|
(13)
|
(13)
|
(10)
|
(6)
|
(8)
|
(8)
|
(4)
|
(2)
|
2
|
(6)
|
(2)
|
(6)
|
(7)
|
|
| Cash from Operating Activities |
(9)
N/A
|
(9)
-1%
|
(10)
-1%
|
(6)
+37%
|
(2)
+65%
|
2
N/A
|
2
+12%
|
(2)
N/A
|
(6)
-298%
|
(7)
-7%
|
(5)
+26%
|
(1)
+88%
|
6
N/A
|
6
+3%
|
8
+32%
|
10
+28%
|
11
+3%
|
16
+51%
|
11
-30%
|
20
+81%
|
20
-2%
|
22
+11%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(9)
|
(4)
|
(4)
|
(3)
|
(31)
|
(33)
|
(36)
|
(39)
|
(15)
|
(16)
|
(13)
|
(12)
|
(9)
|
(8)
|
(8)
|
(8)
|
(7)
|
(5)
|
(5)
|
(4)
|
(5)
|
(8)
|
|
| Other Items |
1
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
2
|
2
|
2
|
2
|
(1)
|
(1)
|
(1)
|
|
| Cash from Investing Activities |
(9)
N/A
|
(4)
+57%
|
(3)
+16%
|
(3)
+16%
|
(31)
-1 100%
|
(34)
-9%
|
(37)
-11%
|
(40)
-6%
|
(15)
+61%
|
(15)
-1%
|
(13)
+17%
|
(13)
+2%
|
(9)
+25%
|
(8)
+11%
|
(8)
+6%
|
(6)
+20%
|
(5)
+19%
|
(4)
+30%
|
(4)
-9%
|
(5)
-30%
|
(6)
-16%
|
(9)
-57%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
1
|
0
|
1
|
25
|
0
|
0
|
24
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(1)
|
0
|
3
|
3
|
10
|
19
|
16
|
16
|
27
|
17
|
16
|
17
|
1
|
3
|
4
|
3
|
1
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Other |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(4)
|
(5)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
| Cash from Financing Activities |
(1)
N/A
|
0
N/A
|
3
+2 367%
|
3
+3%
|
33
+1 132%
|
42
+27%
|
39
-7%
|
40
+1%
|
25
-36%
|
15
-42%
|
14
-7%
|
13
-2%
|
(4)
N/A
|
(2)
+58%
|
(1)
+37%
|
(3)
-129%
|
(3)
-25%
|
(5)
-56%
|
(5)
-10%
|
(6)
-16%
|
(6)
-1%
|
(7)
-4%
|
|
| Change in Cash | |||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(19)
N/A
|
(13)
+31%
|
(10)
+24%
|
(6)
+43%
|
0
N/A
|
10
+2 495%
|
4
-65%
|
(2)
N/A
|
4
N/A
|
(7)
N/A
|
(4)
+44%
|
0
N/A
|
(8)
N/A
|
(4)
+47%
|
(1)
+75%
|
1
N/A
|
2
+64%
|
8
+224%
|
2
-75%
|
9
+365%
|
8
-13%
|
6
-19%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(19)
N/A
|
(14)
+26%
|
(13)
+4%
|
(9)
+31%
|
(33)
-261%
|
(31)
+5%
|
(35)
-11%
|
(41)
-19%
|
(21)
+48%
|
(22)
-5%
|
(18)
+20%
|
(13)
+29%
|
(3)
+73%
|
(2)
+33%
|
0
N/A
|
2
+1 198%
|
4
+84%
|
11
+200%
|
6
-46%
|
16
+179%
|
15
-7%
|
14
-9%
|
|
Switch to:
Switch to:
See Also
Discover More
